ARRY-403

CAS No. 1138669-65-4

ARRY-403( —— )

Catalog No. M34507 CAS No. 1138669-65-4

ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 1502 Get Quote
5MG 1881 Get Quote
10MG 2537 Get Quote
25MG 3643 Get Quote
50MG 4904 Get Quote
100MG 6471 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ARRY-403
  • Note
    Research use only, not for human use.
  • Brief Description
    ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
  • Description
    ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Glucokinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1138669-65-4
  • Formula Weight
    454.52
  • Molecular Formula
    C20H18N6O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1ncccc1Oc1cc(Sc2ccccn2)cnc1Nc1nc(ns1)[C@H](O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Jujuboside A

    Jujuboside A is a glycoside extracted from Semen Ziziphi Spinosae, having neurophysiological inhibitory effects, used as a potential therapeutic agent for the treatment of Alzheimer?s disease.

  • KAN0438757

    KAN0438757 is a selective and potent inhibitor of the metabolic kinase PFKFB3 with an IC50 of 0.19 μM.

  • Diosbulbin B

    Diosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time.